Correlation Between CenterPoint Energy and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CenterPoint Energy and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CenterPoint Energy and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CenterPoint Energy and Spyre Therapeutics, you can compare the effects of market volatilities on CenterPoint Energy and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CenterPoint Energy with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CenterPoint Energy and Spyre Therapeutics.

Diversification Opportunities for CenterPoint Energy and Spyre Therapeutics

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between CenterPoint and Spyre is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding CenterPoint Energy and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and CenterPoint Energy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CenterPoint Energy are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of CenterPoint Energy i.e., CenterPoint Energy and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between CenterPoint Energy and Spyre Therapeutics

Considering the 90-day investment horizon CenterPoint Energy is expected to generate 24.36 times less return on investment than Spyre Therapeutics. But when comparing it to its historical volatility, CenterPoint Energy is 12.57 times less risky than Spyre Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,178  in Spyre Therapeutics on August 24, 2024 and sell it today you would earn a total of  1,592  from holding Spyre Therapeutics or generate 135.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

CenterPoint Energy  vs.  Spyre Therapeutics

 Performance 
       Timeline  
CenterPoint Energy 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in CenterPoint Energy are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, CenterPoint Energy reported solid returns over the last few months and may actually be approaching a breakup point.
Spyre Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Spyre Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

CenterPoint Energy and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CenterPoint Energy and Spyre Therapeutics

The main advantage of trading using opposite CenterPoint Energy and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CenterPoint Energy position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind CenterPoint Energy and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device